Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Patient had scalp allergy from minoxidil; test helped identify cause and suggest alternative treatments.

ALA-photodynamic therapy helps reduce acne by causing acne cell death and lowering certain skin protein levels.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Hydrogen peroxide and monoethanolamine in hair dye can cause dermatitis and hair loss.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Dermatologists need to know about cosmetics to help patients with skin issues and recommend safe products.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.